Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Revenue

Central Pharmaceuticals had revenue of 9.06M BDT in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 34.45M, up 390.88% year-over-year. In the fiscal year ending June 30, 2025, Central Pharmaceuticals had annual revenue of 33.06M with 11.68% growth.

• Revenue (ttm): 34.45M
• Revenue Growth: +390.88%
• P/S Ratio: 29.90
• Revenue / Employee: 465.60K
• Employees: 74
• Market Cap: 1.03B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	33.06M	3.46M	11.68%
Jun 30, 2024	29.60M	271.46K	0.93%
Jun 30, 2023	29.33M	3.33M	12.81%
Jun 30, 2022	26.00M	-122.15M	-82.45%
Jun 30, 2021	148.15M	8.06M	5.75%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 5, 2026

Data Sources Report a data error